The early use of kinetic profiling can help choose the best molecule for progression, this is how Enzymlogic can help you
Juan Manuel Dominguez, Scientific Adviser
Juan Manuel has worked for more than 25 years in drug discovery, both in multinational pharmaceutical corporations (GSK and PharmaMar) as well as small biopharma (Noscira). He has led R&D teams progressing medicines in multiple therapeutic areas, through all phases of development.
Juan Manuel facilitates Enzymlogic’s understanding of industry trends in order to develop new approaches to meet the current and future needs of clients in growing markets.